Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (Wkrd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple Myeloma: A Clinical and Correlative Phase 2 Study
Ola Landgren,Malin Hultcrantz,Alexander M. Lesokhin,Sham Mailankody,Hani Hassoun,Eric L. Smith,Urvi A. Shah,Sydney X. Lu,Donna Mastey,Meghan Salcedo,Victoria Diab,Kelly Werner,Jenna Rispoli,Allison Sams,Dennis Verducci,Katie Jones,Angela Harrison,Aisara Chansakul,Even H. Rustad,Venkata Yellapantula,Francesco Maura,Heather J. Landau,Michael Scordo,David J. Chung,Gunjan Shah,Oscar B. Lahoud,Katie Thoren,Kazunori Murata,Lakshmi Ramanathan,Maria E. Arcila,Caleb Ho,Mikhail Roshal,Ahmet Dogan,Sean M. Devlin,Sergio Giralt,Neha Korde Blood（2020）
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper